Showing results (181-190 of 1,361) with videos related to

Sort By:
Pageof 137
Drugs Under Experimental and Clinical Research|June 3, 2005
Olmesartan medoxomil, a newly developed angiotensin II type 1 receptor antagonist, protects against renal damage in advanced glycation end product (age)-injected ratsS Yamagishi, M Takeuchi, H Inoue
Drugs Under Experimental and Clinical Research|January 1, 1988
Safety profile of ofloxacin in elderly patientsR Fostini, M Girelli, P Dalle Vedove, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Electrocerebral and behavioural analysis of systemic kainic acid-induced epilepsy in the ratM Scerrati, M Onofrj, L Pacifici, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyographyL Rocchi, I Feola, M Calvani, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Antiproliferative activity of picolinic acid due to macrophage activationR Ruffmann, R Schlick, M A Chirigos, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Comparative in vitro susceptibility studies of FCE 22250 and rifampicin on Legionella and Chlamydia trachomatis strainsS Zanetti, D Ungheri, M Castellani Pastoris, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE)S Esposito, D Barba, D Galante, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia sppS Ripa, F Mignini, M Prenna, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Biostatistical aspects of adjuvant therapy assayM Hudec, H Platz
Drugs Under Experimental and Clinical Research|January 1, 1990
The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAIDP Dittrich, S Radhofer-Welte, D Magometschnigg, et al.
Pageof 137